NASH w/o DM | Controls w/o DM | Relative risk (95 % CI) | p | |
---|---|---|---|---|
Incidence of de novo DM at: | ||||
6 months follow-up | 499 (19.2 %) | 1,737 (13.9 %) | 1.38 (1.26–1.51) | <0.0001 |
1 year follow-up | 344 (14.3 %) | 1144 (9.8 %) | 1.46 (1.31–1.64) | <0.0001 |
3 years follow-up | 186 (11.4 %) | 560 (6.8 %) | 1.67 (1.43–1.96) | <0.0001 |
5 years follow-up | 73 (7.4 %) | 275 (5.2 %) | 1.43 (1.12–1.84) | 0.0046 |
Had at least one onset of de novo post-transplant DM by: | ||||
1 year follow-up | 624 (22.9 %) | 2,196 (16.7 %) | 1.37 (1.27–1.49) | <0.0001 |
3 years follow-up | 578 (32.7 %) | 2,004 (22.4 %) | 1.46 (1.35–1.57) | <0.0001 |
5 years follow-up | 425 (39.8 %) | 1,548 (27.0 %) | 1.47 (1.35–1.61) | <0.0001 |
Recorded resolution of post-transplant DM after the first onset | 621 (73.8 %) | 2,205 (74.7 %) | 0.99 (0.94–1.03) | 0.59 |
Time from onset to resolution, years | 1.13 ± 1.06 | 1.07 ± 0.99 | 0.35 | |
Long-term de novo post-transplant DM | 174 (7.6 %) | 481 (4.3 %) | 1.76 (1.49–2.08) | <0.0001 |